Track the 前沿生物 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). The latest transaction was disclosed on 11 August 2026 (Sale). Among the most active insiders: CHANGJIN WANG. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Qianyan Biotechnology is a company focused on the research and development of biotechnology, dedicated to the development and production of innovative drugs. The company is listed on the Chinese stock market with the ticker symbol XSHG.